XML 79 R68.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings Per Share - Calculations of Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Earnings Per Share [Abstract]        
Net Income from Continuing Operations Attributable to Merck & Co., Inc. $ 4,567 $ 2,324 $ 8,525 $ 7,136
Income from Discontinued Operations, Net of Taxes and Amounts Attributable to Noncontrolling Interests 0 617 766 2,025
Net income attributable to Merck & Co., Inc., basic 4,567 2,941 9,291 9,161
Net income attributable to Merck & Co., Inc., diluted $ 4,567 $ 2,941 $ 9,291 $ 9,161
Average common shares outstanding (in shares) 2,530 2,529 2,531 2,530
Common shares issuable (in shares) 6 9 8 11
Average common shares outstanding assuming dilution (in shares) 2,536 2,538 2,539 2,541
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders:        
Income from Continuing Operations (in dollars per share) $ 1.81 $ 0.92 $ 3.37 $ 2.82
Income from Discontinued Operations (in dollars per share) 0 0.24 0.30 0.80
Net Income (in dollars per share) 1.81 1.16 3.67 3.62
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders:        
Income from Continuing Operations (in dollars per share) 1.80 0.92 3.36 2.81
Income from Discontinued Operations (in dollars per share) 0 0.24 0.30 0.80
Net Income (in dollars per share) $ 1.80 $ 1.16 $ 3.66 $ 3.61
Antidilutive shares (in shares) 8 5 10 5